An Act To Limit MaineCare Reimbursement for Methadone Treatment
Maine Legislature, Session 125, LD 1840
Committee Amendment CA_A_H912 (House)
Amends: 22 MRSA §3174-U

COMMITTEE AMENDMENT "A" to H.P. 1361, L.D. 1840, Bill, "An Act To 
Limit MaineCare Reimbursement for Methadone Treatment" 
Amend the bill by striking out everything after the enacting clause and before the 
summary and inserting the following: 
'Sec. 1. 22 MRSA §3174-UU is enacted to read: 
§3174-UU. Methadone reimbursement limitations 
Effective January 1, 2013, reimbursement under the MaineCare program for 
methadone for the treatment of addiction to opiates as defined in Title 17 -A, section 
° 
1, subsection 7 is limited to a lifetime maximum of 24 months, except that 
reimbursement may be provided for longer than 24 months if prior authorization is 
received from the department. 
The department shall adopt rules to implement this section. Rules adopted pursuant 
to this section are routine technical rules as defined in Title 5, chapter 375, subchapter 
2-A. Prior to adopting rules under this section, the department shall seek input from 
stakeholders and experts in the field of substance abuse addiction and recovery, 
including, but not limited to, representatives of the Office of Substance Abuse and 
individuals with expertise in medication-assisted treatment. 
Sec. 2. Appropriations and allocations. The following appropriations and 
allocations are made. 
HEALTH AND HUMAN SERVICES, DEPARTMENT OF (FORMERLY BDS) 
Mental Health Services - Community Medicaid 0732 
Initiative: Reduces funding from savings from limiting MaineCare reimbursement for 
methadone for the treatment of addiction to opioids to a lifetime maximum of 24 months 
with prior authorization beyond 24 months. 
COMMITTEE AMENDMENT 
COMMITTEE AMENDMENT "An to H.P. 1361, L.D. 1840 
GENERAL FUND 
All Other 
GENERAL FUND TOTAL 
Office of Substance Abuse - Medicaid Seed 0844 
2011-12 
$0 
$0 
2012-13 
($491,407) 
($491,407) 
Initiative: Reduces funding from savings from limiting MaineCare reimbursement for 
methadone for the treatment of addiction to opioids to a lifetime maximum of 24 months 
with prior authorization beyond 24 months. 
GENERAL FUND 
All Other 
GENERAL FUND TOTAL 
HEALTH AND HUMAN SERVICES, 
DEPARTMENT OF (FORMERLY BDS) 
DEPARTMENT TOTALS 
GENERAL FUND 
DEPARTMENT TOTAL - ALL FUNDS 
2011-12 
$0 
$0 
2011-12 
$0 
$0 
2012-13 
($141,733) 
($141,733) 
2012-13 
($633,140) 
($633,140) 
HEALTH AND HUMAN SERVICES, DEPARTMENT OF (FORMERLY DHS) 
Medical Care - Payments to Providers 0147 
Initiative: Reduces funding from savings from limiting MaineCare reimbursement for 
methadone for the treatment of addiction to opioids to a lifetime maximum of 24 months 
with prior authorization beyond 24 months. 
GENERAL FUND 
All Other 
GENERAL FUND TOTAL 
FEDERAL EXPENDITURES FUND 
All Other 
FEDERAL EXPENDITURES FUND TOTAL 
2011-12 
$0 
$0 
2011-12 
$0 
$0 
COMMITTEE AMENDMENT 
2012-13 
($730,977) 
($730,977) 
2012-13 
($2,297,941 ) 
($2,297,941 ) 
\ 
fcq 
,,1\ , 
.. , 
COMMITTEE AMENDMENT "A" to H.P. 1361, L.D. 1840 
HEALTH AND HUMAN SERVICES, 
DEPARTMENT OF (FORMERLY DHS) 
DEPARTMENT TOTALS 
GENERAL FUND 
FEDERAL EXPENDITURES FUND 
DEPARTMENT TOTAL-ALL FUNDS 
SECTION TOTALS 
GENERAL FUND 
FEDERAL EXPENDITURES FUND 
SECTION TOTAL - ALL FUNDS 
SUMMARY 
2011-12 
2012-13 
SO 
(S730,977) 
SO 
(S2,297,941) 
SO 
(S3,028,918) 
2011-12 
2012-13 
SO 
(SI,364,117) 
SO 
(S2,297,941) 
SO 
(S3,662,058) 
This amendment is the majority report of the committee. The amendment removes 
from the bill the requirement that methadone services reimbursed under the MaineCare 
program be accessed at the clinic closest to the home of the MaineCare member. The 
amendment removes from the bill the directive to the Department of Health and Human 
Services to review MaineCare transportation services because a similar directive was 
included by the committee in the committee amendment to L.D. 1694. The amendment 
adds to the routine technical rulemaking a requirement that the Department of Health and 
Human Services seek input for the prior authorization rules from stakeholders and experts 
in the field of substance abuse addiction and recovery, including, but not limited to, 
representatives of the Office of Substance Abuse and individuals with expertise in 
medication-assisted treatment. This amendment adds an appropriations and allocations 
section. 
FISCAL NOTE REQUIRED 
(See attached) 
COMMITTEE AMENDMENT 
Revised: 04/03/12 Jtvac. 
LD 1840 
LR 2680(02) 
An Act To Limit MaineCare Reimbursement for Methadone Treatment 
Fiscal Note for Bill as Amended by Committee Amendment nAn C H -q I q) 
Committee: Health and Human Services 
Net Cost (Savings) 
General Fund 
Appropriations/Allocations 
General Fund 
Federal Expenditures Fund 
Revenue 
Federal Expenditures Fund 
Fiscal Detail and Notes 
Fiscal Note Required: Yes 
Fiscal Note 
FY 2011-12 
$0 
$0 
$0 
$0 
FY2012-13 
($1,364,117) 
($1,364,117) 
($2,297,941 ) 
($2,297,941 ) 
Projections 
FY 2013-14 
($2,728,232) 
($2,728,232) 
($4,595,882) 
($4,595,882) 
Projections 
FY 2014-15 
($2,728,232) 
($2,728,232) 
($4,595,882) 
($4,595,882) 
The General Fund savings associated with limiting MaineCare reimbursement for methadone for the treatment of 
addiction to opioids to a lifetime maximum of 24 months with prior authorization beyond 24 months is estimated to be 
$1,364,117 in fiscal year 2012-13. The Federal Expenditures Fund share of the savings is estimated to be $2,297,941 
in fiscal year 2012-13. 
LR2680(02) - Fiscal Note - Page 1 of 1